Searchable abstracts of presentations at key conferences in endocrinology

ea0090p756 | Thyroid | ECE2023

Concordance between the ACR TIRADS ultrasound criteria, the BETHESDA cytopathology classification and final resection result in evaluation of thyroid nodules – Spanish tertiary hospital experience

Jalowiecka Izabela , Garzon Pastor Sandra , Sanz Martinez Olivia , Marti Ibor Encarna , Morillas Arino Carlos

Introduction and Aims: Thyroid lesions constitute a frequent consultation in the area of endocrinology. Fine-needle aspiration (FNA) cytology is a gold standard for the evaluation of thyroid lesions, while ultrasound examination according to various thyroid imaging reporting and data system (TIRADS) criteria is gaining importance in the field. The aim of our study was to compare the sensitivity and specificity of both techniques in patients attended in thyroid lesion unit of o...

ea0049ep755 | Cardiovascular Endocrinology and Lipid Metabolism | ECE2017

PCSK9 inhibitors effects on lipid profile in familial hypercholesterolemia in a specific Lipid Unit: experience in first year commercialization

Gonzalez-Molero Inmaculada , Doulatram Viyu , Marin Monserrat Gonzalo , Abuin Jose , Morillas Virginia , Olveira Gabriel , Tinahones Francisco

Objective: Analyse the features of first patients treated with PCSK9 inhibitors in a specific Familial dyslipidemia Unit and the effects on lipid profile in first months of treatment.Material and methods: Data from patients with heterozygous familial hypercholesterolemia treated with PCSK9 inhibitors were reviewed. Clinical data, physical examination and analytical data were collected at baseline, one month and 3 months.Results: Da...

ea0070aep81 | Adrenal and Cardiovascular Endocrinology | ECE2020

Behavior of adrenal incidentalomas with density computed tomography scan > 10 HU

Modrego Pardo Ines , Garzón Pastor Sandra , Morillas Ariño Carlos

Background: The prevalence of adrenal incidentalomas has increased. The malignancy is determined by radiographic appearance and, secondly, by the size. Adenomas manifest a low attenuation on computed tomography (CT) (<10 Hounsfield Units(HU)).The cut-off point of 10 HU has been proposed to discriminate benign and malignant lesions.Objective: To determine if the cut-off point of 10 HU is useful in clinical practice to discriminate benign and malignant...

ea0029p330 | Cardiovascular Endocrinology and Lipid Metabolism | ICEECE2012

Effect of weight loss on C3 and C4 components of complement in obesity

Victor V. , Banuls C. , Bellod L. , Jover A. , Morillas C. , Falcon R. , Rocha M. , Mijares AHernandez-

Circulating C3 levels are elevated in obese patients, but how this factor is affected after weight loss through diet is a question that is yet unanswered. Therefore, the aim of this study was to evaluate the effects of weight loss on lipid and hydrocarbonated metabolism parameters and on the levels of C3 and C4 components of complement in obese patients. This is a longitudinal intervention study based on a 6 week very low calorie diet (VLCD), a liquid formula of 603 kcal/day. ...

ea0016p571 | Obesity | ECE2008

Inflammatory parameters in obesity: lack of influence of weight loss

Sola Eva , Jover Ana , Garcia Katherinne , Salvador Carlos , Morillas Carlos , Hernandez-Mijares Antonio

Introduction: Obesity has been associated with a low-level activation of the acute-phase response. The aim of the present study was to compare inflammatory parameters in patients with obesity and a control group, and to evaluate the effect of weight loss on these parameters.Methods: Sixty-seven severe or morbid obese patients (51 women, 16 men), aged 34±11 years, were compared with 67 normal-weight controls (45 women, 22 men), aged 32±10 years....

ea0070aep830 | Reproductive and Developmental Endocrinology | ECE2020

Anti-müllerian hormone (AMH) as the primary marker for ovarian reserve in transgender male, with or without pcos, under cronic testosterone treatment

Modrego Pardo Ines , Gómez Balaguer Marcelino , Garzón Pastor Sandra , Morillas Ariño Carlos

Background: AMH represents a marker of ovarian reserve and is used in monitoring the effects of gonadotoxic drugs. In PCOS is higher and is an indirect marker of hyperandrogenism. In transsexual man(TM), high prevalence of PCOS is described and AMH provide information about ovarian reserve after exposure to testosterone.Objective: To assess the prevalence of PCOS in young TM previously to testosterone treatment, study the evolution of AMH levels and diff...

ea0014p198 | (1) | ECE2007

Evaluation of visceral protein malnutrition in morbid obese patients operated on laparoscopic gastric bypass

Casañ Rosa , Morillas Carlos , Sola Eva , García Katherinne , Yanini Jesus , Jover Ana , Gomez Marcelino , Hernández Antonio

Morbid obesity is associated with a decreased life expectancy and a myriad of serious medical problems. The Roux-en-Y gastric bypass (RYGBP) is the most effective procedure for the treatment of these patients, but it can be responsible of early and late complications. The aim of this prospective study was to evaluate the rate of visceral protein malnutrition (VPM) in morbid obese (MO) patients two years after laparoscopic RYGBP. Albumin (Alb), prealbumin (Prealb), transferrin ...

ea0056gp95 | Diabetes Therapy | ECE2018

Randomized control study to compare security and efficacy of the new long acting analogues degludec and glargina U300 in people with type 1 Diabetes. Preliminary results of the Ineox study

Dominguez-Lopez Marta Elena , Vallejo Rosario , Morillas Virginia , Colomo Natalia , Guerrero Mercedes , Rojo Gema , de Adana Navas Marisol Ruiz

Background: There aren’t published randomized studies comparing the clinical impact of degludec and Glragina U300 in the treatment of type 1 diabetes patients. (T1DP)Objective: To compare efficacy and safety of the new long acting analogues Glargine U 300 and Degludec in 300 Type1 diabetes patients treated with basal/bolus treatment.(BBT)Material and methods: Randomized control study 1.1 in 300 T1DP treated with BBT with glarg...

ea0041ep474 | Diabetes (to include epidemiology, pathophysiology) | ECE2016

Pregnancy diabetes in a patient with phenylketonuria: when the diet is complicated

Gonzalo Marin Montserrat , Jose Sanchez Torralbo Francisco , Gonzalez Molero Inmaculada , Morillas Jimenez Virginia , Abuin Fernandez Jose , Contreras Bolivar Victoria , Olveira Fuster Gabriel , Tinahones Madueno Francisco

Precedents: Thirty-nine year old Woman. Classic phenylketonuria diagnosed for neonatal screening in Germany. Good adherence to the diet from the infancy, with good metabolic control. Not response to test with BH4.Pregnancy in 2007 with good controls of phenylalanine (Phe). Son with congenital cardiopathy.Evolution: In 2013 she planed new pregnancy, departing from very good controls (<4 mg/dl) and ingestion of 22–24 Phe&#14...

ea0041ep557 | Diabetes therapy | ECE2016

Randomized clinical trial to compare the effects of glargine multidosis versus CSII therapy on metabolic and oxidative stress parameters in people with type 1 diabetes

de Adana Navas M Soledad Ruiz , Dominguez-Lopez Marta , Rubio Eleazara , Rodriguez Natalia Colomo , Cardona Isabel , Tapia M Jose , Morillas Virgina , Gonzlez Inmaculada , Rojo Gemma

Aims: There are few data comparing oxidative stress markers in CSII versus MDI/G We compared after randomization CSII (Continuous subcutaneous insulin infusion) vs MDI/G therapy (multiple doses of insulin with glargine) in DM1 people previously optimized at MDI/G being the primary objective assessment of metabolic control and oxidative stress.Assess oxidative stress and metabolic control in patients with type 1 diabetes (T1D) after randomization in CSII ...